Feline leukaemia virus: protective immunity is mediated by virus‐specific cytotoxic T lymphocytes
Authors:
Open Access
- 1 September 2000
- journal article
- Published by Wiley in Immunology
- Vol. 101 (1) , 120-125
Abstract
Summary: Feline leukaemia virus (FeLV) nucleic acid vaccination of domestic cats affords protection against viraemia and the development of latency without inducing antiviral antibodies.1To determine the contribution of cell‐mediated immunity to the control of virus replication and clearance from the host, FeLV‐specific cytotoxic T lymphocyte (CTL) responses were compared in vaccine‐protected, transiently viraemic, and persistently viraemic cats. Vaccinal immunity was associated with the detection of higher levels of virus‐specific effector CTL in the peripheral blood and lymphoid organs to FeLV Gag/Pro and Env antigens than those observed in unvaccinated control, persistently viraemic cats (P < 0·001). Likewise, higher levels of virus‐specific CTLs were also observed in transiently viraemic cats which recovered following exposure to FeLV. In cats that controlled their infection, recognition of Gag/Pro antigens was significantly higher than the recognition of Env antigens. This is the first report highlighting the very significant role that virus‐specific CTL have in determining the outcome of FeLV infection in either vaccinated cats or cats recovering naturally from FeLV exposure.Keywords
This publication has 32 references indexed in Scilit:
- Feline Leukemia Virus DNA Vaccine Efficacy Is Enhanced by Coadministration with Interleukin-12 (IL-12) and IL-18 Expression VectorsJournal of Virology, 2001
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Induction of Protective CTL Responses in Newborn Mice by a Murine RetrovirusScience, 1996
- Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccineVeterinary Record, 1996
- Involvement of gag - and env -Specific Cytotoxic T Lymphocytes in Protective Immunity to Feline Immunodeficiency VirusAIDS Research and Human Retroviruses, 1995
- Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cellsThe Lancet, 1995
- Reversal of Feline Leukemia Virus Infection by Adoptive Transfer of Lectin/Interleukin-2-Activated Lymphocytes, Interferon-α, and ZidovudineJournal of Immunotherapy, 1993
- Experimental Vaccine Protection Against Feline Immunodeficiency VirusAIDS Research and Human Retroviruses, 1991
- High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individualsInternational Immunology, 1990
- Protection of kittens from feline leukaemia virus infection by maternally-derived antibody1977